Researchers studied data from surveys of middle-aged individuals from the Middle Aged Danish Twin study and older individuals from the Longitudinal Study of Aging Danish Twins. The researchers examined 2,346 middle-aged individuals who underwent cognitive assessments over a 10-year period, and 2,475 older individuals underwent the assessments over a two-year period.
They also determined cumulative use of PPIs two years prior to study enrollment and during follow up using data from a nationwide prescription register.
In the study of middle-aged individuals, the adjusted difference in mean cognitive scores of those with high consumption of PPI was lower than that of non-users.
In the longitudinal study, individuals with high consumption of PPI had higher adjusted mean cognitive scores than non-users.
Researchers found that no stated differences in cognitive scores between PPI users and non-users were significant.
More articles on healthcare quality:
4 most germ-ridden places for infection spread in offices
GoodRx offers free coupons to slash price of generic Tamiflu
Olympic norovirus outbreak nears 200 cases
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
